Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05097586

RCT of At-Home tDCS for Depression in Pregnancy

Randomized Controlled Trial of At-home Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
156 (estimated)
Sponsor
Women's College Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, sham-controlled trial to determine whether treatment with transcranial direct current stimulation (tDCS) is superior to a sham condition at reducing the symptoms of depression in pregnant people with moderate to severe depression. The study aims to enrol 156 participants across all sites. Data collection occurs at baseline, immediately after treatment, every 4 weeks during pregnancy and 4-, 12-, 26- and 52-weeks postpartum

Detailed description

Transcranial direct current stimulation (tDCS) is a brain stimulation technique for the treatment of depression that has great potential for filling the gap in treatment options for moderate and severe depression in pregnancy. Participants are randomized 1:1 to active tDCS treatment or sham control. After at least one in-person training session with the research team, participants take the tDCS device home and self-administer 30-minute treatments 5 times per week, for 3 weeks, for a total of 15 sessions. Rater-administered and self-report outcomes are collected weekly during the 3-week active treatment phase, every 4 weeks during pregnancy, and at 4-, 12-, 26- and 52-weeks postpartum. A mixed methods process evaluation is embedded into the trial.

Conditions

Interventions

TypeNameDescription
DEVICEactive tDCS2mA of direct current delivered in 15 sessions lasting 30 minutes each over 3 weeks
OTHERworkbookSelf-directed depression in pregnancy workbook completed during each session to control the in-session brain state
DEVICEsham tDCSSham stimulation in which the current turns off after 30 seconds in a slow ramp down that mirrors sensory adaptation in ongoing stimulation, delivered in 15 sessions lasting 30 minutes each over 3 weeks

Timeline

Start date
2021-11-08
Primary completion
2026-01-31
Completion
2027-06-01
First posted
2021-10-28
Last updated
2025-05-28

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT05097586. Inclusion in this directory is not an endorsement.